Both, the KIR B haplotype and the presence of the KIR2DS1 gene in the donor KIR repertoire were associated with a reduced risk of relapse and better relapse-free survival of patients with AML after allogeneic stem cell transplantation (21, 22). This evidence concerns the gene KIR3DL1 and acute myeloid leukemia.